Garcia JS, Swords RT, Roboz GJ, Jacoby MA, et al. Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)]. Leuk Res 2021 Apr 22:106581. doi: 10.1016/j.leukres.2021.106581.
PMID: 33896620